FDA Inspection 1287054 - Apozeal Pharmaceuticals Inc. - October 15, 2025

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Apozeal Pharmaceuticals Inc.

Record Details

This FDA Inspection record concerns Apozeal Pharmaceuticals Inc., with an inspection on October 15, 2025, issued by the Philadelphia District Office, covering human drugs.

Company: Apozeal Pharmaceuticals Inc.
Inspection Date: October 15, 2025
Product Type: Human Drugs
Office: Philadelphia District Office

Open in Dashboard

ID · 5cedf772-ff92-416e-9e31-51a75fbf805a

Violation Codes5

21 CFR 211.160(b)21 CFR 211.19221 CFR 211.22(d)21 CFR 211.67(b)21 CFR 211.68(b)

Full citation text and observation details available on the Dashboard.

FDA Inspection

Apozeal Pharmaceuticals Inc.October 15, 2025